FIM
REGN icon

Fernwood Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Fernwood Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-123
Closed -$118K – 586
2024
Q1 		$118K Buy
+123
New +$117K 0.03% 247

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fernwood Investment Management's REGN Position: Q2 2024 in Review

Fernwood Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q2 2024, closing a stake of 123 shares — an estimated $118K sold.

Fernwood Investment Management first reported a position in REGN in Q1 2024 and held it in 1 quarter. The position peaked at $118K in Q1 2024. 1,332 funds tracked by Wall St. Rank hold REGN as of Q2 2024.

  • Fernwood Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q2 2024 after selling out during the quarter.
  • Fernwood Investment Management sold 123 Regeneron Pharmaceuticals shares in Q2 2024, an estimated $118K.
  • Fernwood Investment Management first reported a position in Regeneron Pharmaceuticals in Q1 2024 and held it in 1 quarter.
  • Fernwood Investment Management's Regeneron Pharmaceuticals position peaked at $118K in Q1 2024.
  • 1,332 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2024.

Based on Fernwood Investment Management's 13F filing for Q2 2024, filed 31 Jul 2024.